PrintThe Burrill Report
The Burrill Report (March 12, 2012): The Single Biggest Opportunity to Improve Health Outcomes (.MP3,14.95 Mb)
An epidemic of chronic diseases, aging populations, and changing lifestyles that come with growing prosperity in emerging economies are threatening to overwhelm healthcare budgets and economic growth. Ernst & Young in its newly issued Progressions report calls changing behaviors the single biggest opportunity to improve health outcomes. We spoke to Glen Giovannetti, Global Life Sciences Leader for Ernst & Young, about the report, the promise of digital health technology to get people to change unhealthy behaviors, and how biopharmaceutical companies themselves will need to change to succeed in this new world of healthcare.
March 09, 2012
http://www.burrillreport.com/article-the_single_biggest_opportunity_to_improve_health_outcomes_.html
BUSINESS STRATEGY
The Single Biggest Opportunity to Improve Health Outcomes
Podcast: March 12, 2012[Please login to post comments]
- Burrill & Company Indices
Read More - Alzheimer’s Costs to Top $200 Billion a Year
New report paints grim picture. Read More - Joint Venture Seeks to Bring Medical Innovation to Russia
Companies will get funding to develop their products in Russia. Read More - Boston Scientific to Acquire Cameron Health for Up to $1.4B
Deal could jumpstart Boston Scientific’s sluggish cardiac defibrillator business. Read More - J&J; Impresses with Prostate Cancer Drug
Interim results on Zytiga show clinical benefit, dampening enthusiasm for Dendreon shares. Read More - Novartis Takes Glivec Arguments to India’s Supreme Court
Outcome of legal battle closely watched by innovators and generic companies alike. Read More - Working Out at Starbucks
Researchers find caffeine alters DNA as much as exercise. Read More - Hospital Quality Reporting Program Had Little Impact on Death Rates
Study questions utility of Hospital Compare in prompting hospitals to improve quality of care. Read More - Cost of Drugs Rockets Past Inflation, Says AARP
While use of generics reduces spending, AARP finds brand and specialty drugs offset savings. Read More - Gilead Falls on News of Additional Hep C Patients Relapsing
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More
.gif)
